Office Adoption Opportunity SinuSys targets an office-based sinus dilation procedure using Vent-Os, aligning with ENT clinics and ambulatory surgery centers seeking minimally invasive treatments under local anesthesia. This creates channel opportunities with distributors and clinical education programs to drive adoption among practitioners who treat chronic sinusitis.

Osmotic Differentiation Advantage The proprietary osmotic technology and gradual self-expanding design differentiate Vent-Os from rapid balloon dilators, suggesting licensing or co development opportunities with larger OEMs to scale manufacturing, regulatory clearance, and global distribution while preserving innovation.

OEM Partnership Pathway Given the presence of large players in ENT devices, SinuSys could pursue strategic partnerships or acquisitions by mid to large size manufacturers or seek exclusive distribution deals to expand market reach and leverage established sales channels.

Lean Sales Strategy As a small company, SinuSys would benefit from outsourced sales forces, clinical education teams, and contract sales organizations to accelerate market entry, along with service contracts and training offerings to create recurring revenue and higher customer retention.

Market and Reimbursement The trend toward in-office, minimally invasive ENT procedures supports a strong business case for payer-focused evidence and case studies; opportunities exist to develop reimbursement strategies, pilot programs, and demonstrate cost savings to hospitals and clinics.